Previous Client

Return to Sector or view our Current Clients.

Untitled Document

PanGenex Corp. (PGCX)

PanGenex Corp. (PGCX) is a nutraceutical and dietary supplement developer focused on pursuing business opportunities in the $70 billion nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, the company develops and markets sector-leading, patented or patent-pending, condition-specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products.

Many of the PanGenex's products are available anywhere without a prescription. Primary products offered by the company include Calci-Clear, LIPIDEME and Omeganol, all of which address Soft Tissue Calcification (STC), an abnormal hardening or thickening of soft tissues (such as arteries). This condition is linked to over half of chronic diseases and currently affects an estimated 196 million Americans, or 60 percent of the U.S. population.

Since 2006, PanGenex has voluntarily submitted its product labels to the FDA without incidence. The company's products are currently sold to healthcare practitioners in 20 U.S. states, Canada, Puerto Rico, Canada, Brazil, and Australia as well as online at www.HeartHealthyWorld.com.

PanGenex Corp. Message Board

PanGenex Corp. Blog


The QualityStocks

Read the articles covering the biggest movers in the markets today.



Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.


The QualityStocks Daily

Go back to see our previous newsletters and find out what you might have missed.